Fig. 5From: Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson’s disease models(A) Real-time graph and (B) representative images of live-cell IncuCyte MitoSox red assay for control and treated cells (marked in red). Scale bar: 200 μm. (C) Images of mPTP assay and (D) histograms of green fluorescence quantification (calcein-AM/cobalt chloride). Scale bar: 50 μm. (E) Real-time graph and (F) representative images of live-cell IncuCyte TMRM assay for control and treated cells (marked in red). *** p < 0.0005 vs. control (CTR). +++p < 0.0005 vs. 6-OHDABack to article page